Finances
Build lab financial resilience using hybrid budgeting models, vendor partners, and TCO tools
| 5+ min read
With an earnings beat and a transformative decision to divest its China immunodiagnostics business, Revvity is doubling down on high-growth life sciences and AI-powered software.
| 3 min read
With double-digit revenue growth and the launch of a new Transformation Office, Repligen signals a shift toward high-efficiency bioprocessing and optimized manufacturing footprints
| 3 min read
With the successful integration of BD’s Biosciences and Diagnostic Solutions, Waters Corporation signals a shift toward high-growth regulated testing and advanced diagnostics.
| 3 min read
As academic funding tightens and regional conflicts impact supply chains, Bio-Rad shifts strategy toward tiered product launches and organizational optimization.
| 3 min read
A 30% surge in bioprocessing equipment orders, a new mRNA purification platform from Cytiva, and a frank discussion of tariff pressures make Danaher's latest earnings call required reading for lab leaders
| 5 min read
From a next-gen cryo-EM to a smarter electronic pipette, the company's Q1 earnings call painted a detailed picture of where lab technology is heading — and what's putting pressure on budgets.
| 4 min read
Developing financial literacy is vital to the lab’s and the manager’s success
| 3 min read
